Close
Xylem
Novotech

Press Releases

Univercells Technologies and VectorBuilder announce strategic partnership for optimized custom viral vector production

Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production, has formed a worldwide strategic partnership with VectorBuilder, a global leader in vector design, optimization and manufacturing. Univercells Technologies will work with VectorBuilderโ€™s manufacturing...

Bharat Biotech concludes final analysis for Covaxin efficacy from phase 3 clinical trials

Bharat Biotech, a global leader in vaccine development and innovation, announced safety and efficacy analysis data from Phase III clinical trials of COVAXINยฎ, a whole virion inactivated vaccine against SARS-CoV2, was developed in partnership with ICMR and NIV Pune. Phase...

Siemens and BioNTech expand their collaboration for global vaccine production

German biotechnology company BioNTech SE and Siemens intend to expand their strategic cooperation. The companies plan to intensify their collaboration for the rapid expansion and creation of production capacity for the Covid-19 vaccine . German biotechnology company BioNTech SE and...

Turkish Cargo Carried 100 million Vaccine Doses to All Around the World

As the cargo company that flies to more countries than any other, Turkish Cargo continues to fly uninterrupted and contributes to the fight against the pandemic for the return to better days. Managing to grow under the leadership of...

Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19

Cipla Limited, Dr. Reddyโ€™s Laboratories Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, and Torrent Pharmaceuticals Limited, announced that the five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of...

Sanofi launches dedicated vaccines mRNA Center of Excellence

Sanofi will invest approximately โ‚ฌ400 million annually in a first-of-its kind vaccines mRNA Center of Excellence. The Center will work to accelerate the development and delivery of next-generation vaccines by bringing together approximately 400 dedicated employees integrating end-to-end mRNA...

Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the government of India has issued a registration certificate and a permission to import the COVID-19 Vaccine Moderna for restricted use in an emergency situation. โ€œI...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป